11-6393961-A-G
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_000543.5(SMPD1):c.1406A>G(p.Tyr469Cys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y469S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000543.5 missense
Scores
Clinical Significance
Conservation
Publications
- acid sphingomyelinase deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Niemann-Pick diseaseInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- Niemann-Pick disease type AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
- Niemann-Pick disease type BInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000543.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMPD1 | NM_000543.5 | MANE Select | c.1406A>G | p.Tyr469Cys | missense | Exon 5 of 6 | NP_000534.3 | ||
| SMPD1 | NM_001007593.3 | c.1403A>G | p.Tyr468Cys | missense | Exon 5 of 6 | NP_001007594.2 | |||
| SMPD1 | NM_001365135.2 | c.1274A>G | p.Tyr425Cys | missense | Exon 4 of 5 | NP_001352064.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SMPD1 | ENST00000342245.9 | TSL:1 MANE Select | c.1406A>G | p.Tyr469Cys | missense | Exon 5 of 6 | ENSP00000340409.4 | ||
| SMPD1 | ENST00000526280.1 | TSL:1 | c.461A>G | p.Tyr154Cys | missense | Exon 3 of 4 | ENSP00000436278.1 | ||
| SMPD1 | ENST00000531303.5 | TSL:1 | n.*237A>G | non_coding_transcript_exon | Exon 5 of 6 | ENSP00000432625.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Pathogenic:2
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 469 of the SMPD1 protein (p.Tyr469Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Niemann-Pick disease (PMID: 33675270). ClinVar contains an entry for this variant (Variation ID: 992707). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function. This variant disrupts the p.Tyr469 amino acid residue in SMPD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19405096, 30795770). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Niemann-Pick disease, type B Pathogenic:1
The variant is not observed in the gnomAD v4.1.0 dataset. Predicted Consequence/Location: Missense variant In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.93 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.98 (>=0.6, sensitivity 0.72 and precision 0.9)]. The same nucleotide change resulting in the same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000992707 /PMID: 33675270). A different missense change at the same codon (p.Tyr469Ser) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000002996 /PMID: 19405096). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Sphingomyelin/cholesterol lipidosis Pathogenic:1
Variant summary: SMPD1 c.1406A>G (p.Tyr469Cys) results in a non-conservative amino acid change located in the metallophosphatase domain (IPR041805) of the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function all suggest that this variant is likely to be disruptive. The variant was absent in 251494 control chromosomes (gnomAD). c.1406A>G has been observed in individuals affected with Niemann-Pick Disease (Hu_2021). A different variant affecting the same codon has been classified as pathogenic by our lab (c.1406A>C, p.Tyr469Ser), supporting the critical relevance of codon 469 to SMPD1 protein function. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 33675270). ClinVar contains an entry for this variant (Variation ID: 992707). Based on the evidence outlined above, the variant was classified as likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at